Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Agitation | Research

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

Authors: Sileshi Belew, Sultan Suleman, Markos Duguma, Henok Teshome, Evelien Wynendaele, Luc Duchateau, Bart De Spiegeleer

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust and discriminatory dissolution method is crucial. Therefore, the aim of this study was to develop and validate an appropriate dissolution method for quality control of FDC ART/LUM tablets.

Methods

The dissolution medium was selected based on saturation solubility data and sink conditions. The effect of agitation speed, pH and surfactant concentration on the release of ART and LUM was evaluated by employing a two-level factorial experiment. The resulting final method was validated for linearity, precision, robustness and API stability. In addition, the discriminatory power of the method was evaluated using expired and unexpired FDC ART/LUM products.

Results

A suitable dissolution profile of FDC ART/LUM tablets was obtained in 900 ml HCl (0.025 N, pH 1.6) with 1%Myrj 52 using paddle method at 100 rpm and 37 °C. ART and LUM were analysed using a HPLC method with UV detection at wavelengths of 210 and 335 nm, respectively. The results from the stability study showed that ART and LUM were sufficiently stable in HCl (0.025 N, pH 1.6) with 1%Myrj 52 at 37 °C. The method was linear (r2 = 0.999) over the concentration range of 6.25–100 μg/ml. The results for precision were within the acceptance limit (%RSD < 2). The percent relative standard deviation (< 2%) and statistically non-significant (p > 0.05) difference in release of ART and LUM observed between deliberately changed dissolution method settings (pH = 1.6 ± 0.2 or agitation speed = 100 ± 2) and optimized dissolution conditions revealed the robustness of the dissolution method. The method was capable to discriminate among different FDC ART/LUM products with different quality.

Conclusions

The developed dissolution method is robust and discriminatory. It can be used in the quality evaluation of FDC ART/LUM tablets.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nega D, Assefa A, Mohamed H, Solomon H, Woyessa A, Assefa Y, et al. Therapeutic efficacy of artemether-lumefantrine (Coartem®) in treating uncomplicated Plasmodium falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study. PLoS ONE. 2016;11:e0154618.CrossRef Nega D, Assefa A, Mohamed H, Solomon H, Woyessa A, Assefa Y, et al. Therapeutic efficacy of artemether-lumefantrine (Coartem®) in treating uncomplicated Plasmodium falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study. PLoS ONE. 2016;11:e0154618.CrossRef
2.
go back to reference Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.CrossRef Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.CrossRef
4.
go back to reference Adjei GO, Goka BQ, Binka F, Kurtzhals JA. Artemether-lumefantine: an oralantimalarial for uncomplicated malaria in children. Expert Rev Anti Infect Ther. 2009;7:669–81.CrossRef Adjei GO, Goka BQ, Binka F, Kurtzhals JA. Artemether-lumefantine: an oralantimalarial for uncomplicated malaria in children. Expert Rev Anti Infect Ther. 2009;7:669–81.CrossRef
5.
go back to reference Kokwaro G, Mwai L, Nzila A. Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin Pharmacother. 2007;8:75–94.CrossRef Kokwaro G, Mwai L, Nzila A. Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin Pharmacother. 2007;8:75–94.CrossRef
6.
go back to reference Itoh M, Negreiros do Valle S, Farias S, Holanda de Souza TM, RachidViana GM, Lucchi N, et al. Efficacy of artemether–lumefantrine for uncomplicated Plasmodium falciparum malaria in Cruzeiro doSul, Brazil. Am J Trop Med Hyg. 2018;98:88–94.CrossRef Itoh M, Negreiros do Valle S, Farias S, Holanda de Souza TM, RachidViana GM, Lucchi N, et al. Efficacy of artemether–lumefantrine for uncomplicated Plasmodium falciparum malaria in Cruzeiro doSul, Brazil. Am J Trop Med Hyg. 2018;98:88–94.CrossRef
8.
go back to reference Visser BJ, van Vugt M, Grobusch MP. Malaria: an update on current chemotherapy. Expert Opin Pharmacother. 2014;15:2219–54.CrossRef Visser BJ, van Vugt M, Grobusch MP. Malaria: an update on current chemotherapy. Expert Opin Pharmacother. 2014;15:2219–54.CrossRef
9.
go back to reference Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007;297:2210–9.CrossRef Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007;297:2210–9.CrossRef
10.
go back to reference Amin NC, Fabre H, Blanchin MD, Montels J, Ake M. Determination of artemether and lumefantrine in anti-malarial fixed-dose combination tablets by microemulsion electrokinetic chromatography with short-end injection procedure. Malar J. 2013;12:202.CrossRef Amin NC, Fabre H, Blanchin MD, Montels J, Ake M. Determination of artemether and lumefantrine in anti-malarial fixed-dose combination tablets by microemulsion electrokinetic chromatography with short-end injection procedure. Malar J. 2013;12:202.CrossRef
12.
go back to reference Kim J, Jung DH, Rhee H, Choi SH, Sung NJ, Choi WS. Aqueous solubility of poorly water-soluble drugs: prediction using similarity and quantitative structure-property relationship models. Korean J Chem Eng. 2008;25:865.CrossRef Kim J, Jung DH, Rhee H, Choi SH, Sung NJ, Choi WS. Aqueous solubility of poorly water-soluble drugs: prediction using similarity and quantitative structure-property relationship models. Korean J Chem Eng. 2008;25:865.CrossRef
13.
go back to reference Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. The biopharmaceutics classification system: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014;57:152–63.CrossRef Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. The biopharmaceutics classification system: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014;57:152–63.CrossRef
14.
go back to reference Jambhekar SS, Breen PJ. Drug dissolution: significance of physicochemical properties and physiological conditions. Drug Discov Today. 2013;18:1173–84.CrossRef Jambhekar SS, Breen PJ. Drug dissolution: significance of physicochemical properties and physiological conditions. Drug Discov Today. 2013;18:1173–84.CrossRef
15.
go back to reference Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42:620–43.CrossRef Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42:620–43.CrossRef
16.
go back to reference Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–40.CrossRef Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–40.CrossRef
17.
go back to reference Xia D, Cui F, Piao H, Cun D, Piao H, Jiang Y, et al. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats. Pharm Res. 2010;27:1965–2776.CrossRef Xia D, Cui F, Piao H, Cun D, Piao H, Jiang Y, et al. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats. Pharm Res. 2010;27:1965–2776.CrossRef
18.
go back to reference Korbely A, Kelemen A, Kasa P, Pintye-hodi K. Effects of processing on the release profiles of matrix systems containing 5-aminosalicyclic acid. AAPS Pharm Sci Tech. 2012;13:1341–7.CrossRef Korbely A, Kelemen A, Kasa P, Pintye-hodi K. Effects of processing on the release profiles of matrix systems containing 5-aminosalicyclic acid. AAPS Pharm Sci Tech. 2012;13:1341–7.CrossRef
19.
go back to reference Nanjwade B, Ali S, Nanjwade V, Manvi F. Effect of compression pressure on dissolution and solid-state characterization of cefuroxime axetil. J Anal Bioanal Tech. 2010;1:112. Nanjwade B, Ali S, Nanjwade V, Manvi F. Effect of compression pressure on dissolution and solid-state characterization of cefuroxime axetil. J Anal Bioanal Tech. 2010;1:112.
20.
go back to reference Zhao J, Koo O, Pan D, Wu Y, Morkhade D, Rana S, et al. The impact of disintegrant type, surfactant and API properties on the processability and performance of roller compacted formulations of acetaminophen and aspirin. AAPS J. 2017;19:1387–95.CrossRef Zhao J, Koo O, Pan D, Wu Y, Morkhade D, Rana S, et al. The impact of disintegrant type, surfactant and API properties on the processability and performance of roller compacted formulations of acetaminophen and aspirin. AAPS J. 2017;19:1387–95.CrossRef
21.
go back to reference Niranjan P, Reddy V, Reddy G, Panda K. Effect of different grades of hpmc and eudragit on drug release profile of doxofylline sustained release matrix tablets and IVIVC studies. Int Res J Pharm. 2015;6:493–504.CrossRef Niranjan P, Reddy V, Reddy G, Panda K. Effect of different grades of hpmc and eudragit on drug release profile of doxofylline sustained release matrix tablets and IVIVC studies. Int Res J Pharm. 2015;6:493–504.CrossRef
22.
go back to reference Ren S, Liu M, Hong C, Li G, Sun J, Wang J. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals. Acta Pharm Sin B. 2019;9:59–73.CrossRef Ren S, Liu M, Hong C, Li G, Sun J, Wang J. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals. Acta Pharm Sin B. 2019;9:59–73.CrossRef
23.
go back to reference Rivelli GG, Ricoy LBM, Cesar IC, Fernandes C, Pianetti GA. Level A in vitro-in vivo correlation: application to establish a dissolution test for artemether and lumefantrine tablets. J Pharm Biomed Anal. 2018;155:262–9.CrossRef Rivelli GG, Ricoy LBM, Cesar IC, Fernandes C, Pianetti GA. Level A in vitro-in vivo correlation: application to establish a dissolution test for artemether and lumefantrine tablets. J Pharm Biomed Anal. 2018;155:262–9.CrossRef
24.
go back to reference Umapathi P, Ayyappan J, Quine S. Development and validation of a dissolution test method for artemether and lumefantrine in tablets. Trop J Pharm Res. 2011;10:643–53. Umapathi P, Ayyappan J, Quine S. Development and validation of a dissolution test method for artemether and lumefantrine in tablets. Trop J Pharm Res. 2011;10:643–53.
25.
go back to reference European Pharmacopoeia, 9th ed. (9.8). Chapter 2.9.5. mass uniformity of single dose preparations. European Directorate for Quality of Medicines and Health Care. Strasbourg, France; 2019, p. 311–2. European Pharmacopoeia, 9th ed. (9.8). Chapter 2.9.5. mass uniformity of single dose preparations. European Directorate for Quality of Medicines and Health Care. Strasbourg, France; 2019, p. 311–2.
26.
go back to reference Suleman S, Vandercruyssen K, Wynendaele E, D’Hondt M, Bracke N, et al. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products. Malar J. 2013;12:145.CrossRef Suleman S, Vandercruyssen K, Wynendaele E, D’Hondt M, Bracke N, et al. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products. Malar J. 2013;12:145.CrossRef
27.
go back to reference European Pharmacopoeia, 9th ed. Chapter 2.2.46. Chromatographic separation techniques. European Directorate for Quality of Medicines and Health Care. Strasbourg, France; 2019, p. 4286–93. European Pharmacopoeia, 9th ed. Chapter 2.2.46. Chromatographic separation techniques. European Directorate for Quality of Medicines and Health Care. Strasbourg, France; 2019, p. 4286–93.
28.
go back to reference D’Hondt M, Wynendaele E, Vandercruyssen K, Bauters T, Vandenbroucke J, Mullens S, et al. Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules. J Pharmaceut Biomed. 2014;96:68–76.CrossRef D’Hondt M, Wynendaele E, Vandercruyssen K, Bauters T, Vandenbroucke J, Mullens S, et al. Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules. J Pharmaceut Biomed. 2014;96:68–76.CrossRef
29.
go back to reference Baka E, Comer JEA, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake–flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335–41.CrossRef Baka E, Comer JEA, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake–flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335–41.CrossRef
30.
go back to reference da Sila AS, da Rosa Silva CE, Paula FR, da Silva FEB. Discriminative dissolution method for benzoyl metronidazole oral suspension. AAPS Pharm Sci Tech. 2016;17:778–86.CrossRef da Sila AS, da Rosa Silva CE, Paula FR, da Silva FEB. Discriminative dissolution method for benzoyl metronidazole oral suspension. AAPS Pharm Sci Tech. 2016;17:778–86.CrossRef
31.
go back to reference Gabbott IP, Al Husban F, Reynolds GK. The combined effect of wet granulation process parameters and dried granule moisture content on tablet quality attributes. Eur J Pharm Biopharm. 2016;106:70–8.CrossRef Gabbott IP, Al Husban F, Reynolds GK. The combined effect of wet granulation process parameters and dried granule moisture content on tablet quality attributes. Eur J Pharm Biopharm. 2016;106:70–8.CrossRef
32.
go back to reference Bejugam NK, Parish HJ, Shankar GN. Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design. AAPS PharmSci Tech. 2009;10:1437.CrossRef Bejugam NK, Parish HJ, Shankar GN. Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design. AAPS PharmSci Tech. 2009;10:1437.CrossRef
33.
go back to reference Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. IlFarmaco. 2005;60:840–6.CrossRef Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. IlFarmaco. 2005;60:840–6.CrossRef
34.
go back to reference Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm. 2006;321:1–11.CrossRef Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm. 2006;321:1–11.CrossRef
35.
go back to reference Qureshi S. Developing discriminatory drug dissolution tests and profiles: some thoughts for consideration on the concept and its interpretation. Dissolution Technol. 2006;13:18–23.CrossRef Qureshi S. Developing discriminatory drug dissolution tests and profiles: some thoughts for consideration on the concept and its interpretation. Dissolution Technol. 2006;13:18–23.CrossRef
36.
go back to reference Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46:75–87.CrossRef Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46:75–87.CrossRef
37.
go back to reference Abdou HM. Dissolution, bioavailability and bioequivalence. Drug Dev Ind Pharm. 1990;16:185–6.CrossRef Abdou HM. Dissolution, bioavailability and bioequivalence. Drug Dev Ind Pharm. 1990;16:185–6.CrossRef
38.
go back to reference Sathe P, Tsong Y, Shah VP. In-vitro dissolution profile comparison and IVIVR. Carbamazepine case. Adv Exp Med Biol. 1997;423:31–42.CrossRef Sathe P, Tsong Y, Shah VP. In-vitro dissolution profile comparison and IVIVR. Carbamazepine case. Adv Exp Med Biol. 1997;423:31–42.CrossRef
39.
go back to reference Butler JM, Dressman JB. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci. 2010;99:4940–54.CrossRef Butler JM, Dressman JB. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci. 2010;99:4940–54.CrossRef
Metadata
Title
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
Authors
Sileshi Belew
Sultan Suleman
Markos Duguma
Henok Teshome
Evelien Wynendaele
Luc Duchateau
Bart De Spiegeleer
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Agitation
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03209-5

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue